Skip to main content
VulnerabilityPublished

CVE-2026-32868: OPEXUS eComplaint · Cross-site Scripting

Affects OPEXUS eComplaintSource CVE Database V5

0
Compare

Not known to be exploited · CVSS 5.1 Medium : upgrade to 10.2.0.0 when convenient.

Data as of 31 Oct 2026, 20:20 UTC

CVSS 4.0 base score
5.1Medium
How severe the flaw is on the 0–10 CVSS scale.
EPSS
0.1% chance of exploitation in 30 days – higher than 3% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
Patch
Available – fixed in 10.2.0.0
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:P/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N

Exploitation evidence

  1. Disclosed: evidence found.

    CVE published 19 Mar 2026

  2. Detectable: no evidence on record.

    No public nuclei template indexed

  3. Weaponized: no evidence on record.

    No public exploit code indexed in Metasploit or Exploit-DB

  4. Exploited in the wild: no evidence on record.

    Not in CISA KEV and no source reports exploitation

  5. Observed by OffSeq Mirage: no evidence on record.

    No attack traffic recorded by OffSeq Mirage sensors

A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 31 Oct 2026.

What to do

Upgrade eComplaint and eCASE to 10.2.0.0.

Affected software

ProductAffectedFixed in
OPEXUSeComplaintAffected
  • <10.2.0.0
Fixed in
  • 10.2.0.0
OPEXUSeCASEAffected
  • <10.2.0.0
Fixed in
  • 10.2.0.0

AI-suggested

Organizations should upgrade OPEXUS eComplaint and eCASE to version 10.2.0.0 or later once available to fully remediate this vulnerability. In the interim, implement strict input validation and output encoding on all user-supplied data fields, especially first and last name inputs, to neutralize malicious scripts. Employ Content Security Policy (CSP) headers to restrict script execution sources and reduce XSS impact. Conduct regular user training to recognize suspicious behavior and limit privilege escalation. Monitor application logs for unusual input patterns or script injection attempts. Consider implementing multi-factor authentication to reduce risk from compromised credentials. Engage with OPEXUS support for any available patches or workarounds and apply web application firewalls (WAF) with custom rules targeting XSS payloads in user input fields. Regularly review and update security policies related to web application security.

Description

CVE-2026-32868 is a medium severity cross-site scripting (XSS) vulnerability in OPEXUS eComplaint and eCASE products before version 10.2.0.0. It arises from improper sanitization of user input in the first and last name fields on the 'My Information' screen. An authenticated attacker can inject malicious scripts into these fields, which execute when the victim views the full name, allowing script execution in the victim’s session context. This vulnerability requires low privileges but does require user interaction to trigger the payload. No known exploits are currently reported in the wild. The vulnerability impacts confidentiality, integrity, and availability to a limited extent due to script execution capabilities. Organizations using affected versions should prioritize patching or apply input validation and output encoding controls to mitigate risk.

References

Community reviews

Loading reviews…